Clinical Trial

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 9, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
the goal of this study is To describe the clinical, hematologic, and cytogenetic characteristics of CLL cases. The main questions it aims to answer are: 1. what is the impact of cytogenetics abnormalities \[e.g., IGHV mutation status, del(17p)\] on patients' treatment response? 2. what is th correlation between clinical and hematological characteristic with patients' outcome. All participants will be subjected to history taking , Physical examination. and Laboratory investigations (Complete blood picture Cytogenetic profiles: del(17p) molecular study :IGHV mutation status).
Trial Details
NCT Number NCT07162532
Lead Sponsor Assiut University
Conditions Chronic Lymphocytic Leukemia (CLL)
Enrollment 45 participants
Start Date 2025-10-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-09